Cargando…
Periodontal therapeutics: Current host‐modulation agents and future directions
With the recognition in the 1960s and 1970s of the periodontopathic importance of the microbial biofilm and its specific anaerobic microorganisms, periodontitis was treated as an infectious disease (more recently, as a dysbiosis). Subsequently, in the 1980s, host‐response mechanisms were identified...
Autores principales: | Golub, Lorne M., Lee, Hsi‐Ming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6973248/ https://www.ncbi.nlm.nih.gov/pubmed/31850625 http://dx.doi.org/10.1111/prd.12315 |
Ejemplares similares
-
Current knowledge and future direction of research on soy isoflavones as a therapeutic agents
por: Kalaiselvan, V., et al.
Publicado: (2010) -
Treating chronic periodontitis: current status, challenges, and future directions
por: Shaddox, Luciana M, et al.
Publicado: (2010) -
Host modulation by therapeutic agents
por: Elavarasu, Sugumari, et al.
Publicado: (2012) -
The pleotropic role of statins: Could it be the imminent host modulation agent in periodontics?
por: Grover, Harpreet Singh, et al.
Publicado: (2013) -
Algal Phlorotannins as Novel Antibacterial Agents with Reference to the Antioxidant Modulation: Current Advances and Future Directions
por: Pradhan, Biswajita, et al.
Publicado: (2022)